Journal
Journal of Clinical Oncology
Publication Date
4-1-2023
Volume
41
Issue
10
First Page
1864
Last Page
1875
Document Type
Open Access Publication
DOI
10.1200/JCO.22.00958
Rights and Permissions
Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ. Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study. J Clin Oncol. 2023 Apr 1;41(10):1864-1875. doi: 10.1200/JCO.22.00958. Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
Recommended Citation
Kitko, Carrie L; Pusic, Iskra; and et al., "Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: Results of a phase I/II study." Journal of Clinical Oncology. 41, 10. 1864 - 1875. (2023).
https://digitalcommons.wustl.edu/oa_4/1642
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.